Health Canada Issues Resverlogix Authorization to Begin Immediate Clinical Studies of Apabetalone for COVID-19 Apr 12, 2021 Read More
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Two New License Approvals from Health Canada for its MultiX Barium Sulfate Powder Covering Oral and Rectal Applications – Video Available on Investmentpitch.com Apr 7, 2021 Read More
Apabetalone’s Beneficial Effects on COVID-19 Published in Prestigious Scientific Journal Cell Mar 17, 2021 Read More
Zenith Epigenetics Announces Dosing of First mCRPC Patient with a Combination of ZEN-3694 + Merck’s Immune Check Point Inhibitor KEYTRUDA Mar 15, 2021 Read More
